Search - tctmd.com

Displaying 241 - 259 of 259

Sort: Relevancy | Date

News Daily News

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Jason Kahn

September 08, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Daily News

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

L.A. McKeown

August 19, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

News Daily News

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

May 16, 2011

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Conference News

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

L.A. McKeown

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

News Daily News

Meta-Analysis Confirms Superiority of Simple Stenting for Bifurcations

L.A. McKeown

January 10, 2011

Advertisement

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

EES Show Long-term Safety Advantage over SES

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

Therapies Take on In-Stent Restenosis with Mixed Results

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Meta-Analysis Confirms Superiority of Simple Stenting for Bifurcations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content